CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 19,379 shares (grant or award)
- 4 Grant or award CEO & President acquired 11,627 shares (grant or award)
- 4 Grant or award CEO & President acquired 11,194 shares (grant or award)
- 4 Grant or award CEO & President acquired 10,204 shares (grant or award)
- 4 Grant or award CEO & President acquired 9,146 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
Page 21 of 82 · 1,637 filings